96
Participants
Start Date
January 14, 2016
Primary Completion Date
September 27, 2022
Study Completion Date
September 27, 2022
Idelalisib
Idelalisib tablet administered orally
Calvary Norht Adelaide Hosptial, Woodville South
Hospital San Pedro de Alcantara, Cáceres
Fakultni nemocnice Kralovske Vinohrady, Prague
SCDU Ematologia e Terapie Cellulari Azienda Ospedaliera Ordine Mauriziano di Torino, Orbassano
Dipartimento di Ematologia ed Oncoematolgia - S.C Ematolgia, Torino
Ospedale Policlinico San Martino IRCCS-Clinica Ematologica, Genoa
Azienda Policlinico San Martino, Genova
IRCCS Ospendale San Raffaele, Milan
Azienda Ospedaliera Papa Giovanni XXIII, Bergamo
ASST Spedali Civili, Brescia
Hospital General Universiario Gregorio Maranon, Madrid
Hospital Universitario Infanta Leonor, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Fundacion Jimenez Diaz, Madrid
Centro Integral Oncologico Clara Campal (CIOCC), Madrid
Hospital Puerta de Hierro Majadahonda, Majadahonda
Hospital Genereal Universitario Morales Meseguer, Murcia
Polyclinique Bordeaux Nord Aquitaine, Bordeaux
A.S.U. Integrata Santa Maria della Misericordia, Udine
Carmel Medical Center, Haifa
Centre Hospitalier de Tours-Hopital Bretoneau Centre Regional de Cancerologie Henry Kaplan, Tours
Hospital Universitario de Canarias, Santa Cruz de Tenerife
Hospital Universitario Marques de Valdecilla, Santander
CEIm-Regional De La Comunidad De Madrid, Valencia
Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Dipartimento di Oncologia Medica, Meldola
Ospedale degli Infermi-Oncoematologia, Rimini
Azienda Unita Sanitaria Locale di Ravenna, U.O di Ematologia, Ravenna
Hospital Clinico Universitario Lozano Blesa, Zaragoza
Clinique Louis Pasteur, Vandoeuvre-lés-Nancy
Hopital Saint Antoine, Paris
Centre Hospitalier Le Mans, Le Mans
Azienda Ospedaliera Cardinale G Panico di Tricase-Unita Operativa Complessa di Ematologia e TMO, Lecce
Azienda Ospedaliera Vito Fazzi Unita Operativa di Ematologia, Lecce
Hopital Saint Louis, Paris
Centre Hospitalier d'Avignon-Hopital Henri Duffaut, Avignon
Centre Hospitalier Universaitaire de Poit iers-Pole Regional de Cancerlogie, Poitiers
Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo
"Spitalul Judetean de Urgenta Dr. Constantin Opris Baia Mare", Baia Mare
Meir Medical Center, Kfar Saba
Royal Victoria Regional Health Centre, Barrie
Fakultni nemocnice Brno, Interni hematologicka a onkologicka klinika, Brno
Fakulni newmcince v Motole, Onkologicka klinika 2. LF UK a FN Motol, Prague
Fondazione Policlinico Tor Vergata-UOC Patologie Linfoproliferative, Rome
Ospedale S. Eugenio, Rome
Szpitale Wojewodzkie w Gdyni Sp. z o.o., Gdynia
PRATIA Onkologia Katowice, Katowice
Malopolskie Centrum Medyczne, Krakow
Wojewodzki Szpital Specjalistyczny w Legniicy, Legnica
Gabinety Lekarskie Hema, Lublin
Szpital Wojewodzki w Opolu Sp. z o.o., Opole
Instytut Hematologii i Transfuzjologii, Klinika Hematologii, Warsaw
Centrum Onkologii Instytut im.Marii Sklodowskiej Curie, Warsaw
Klinika Hematologii Nowotworow Kriwi i Transplantacji Szpiku, Wroclaw
Hospital del Mar, Barcelona
Hospital Universitario de Burgos, Burgos
Institut Catala d'Oncologia Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat
Hospital Son Llatzer, Palma de Mallorca
Hospital Universitario Mutua Terrassa, Terrassa
East Kent Hospitals University NHS Foundation Trust, Canterbury
London North West University Healthcare NHS Trust, Harrow
Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool
Barts Health Trust, London
University College London Hospitals NHS Foundation Trust, London
St George's Hospital NHS Trust, London
The Pennine Acute Hospital NHS Trust, Oldham
Torbay and South Devon NHS Foundation Trust, Torquay
Lead Sponsor
Gilead Sciences
INDUSTRY